National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle income countries

References

• World Federation of Hemophilia. Report on the annual global survey 2021
   Google Scholar
• Iorio A, Stonebraker JS, Chambost H, et al. Establishing the prevalence and the prevalence at birth of hemophilia in males; a meta-analytic approach using national registries. Ann Intern Med. 2019;17(8):540–6. doi: 10.7326/M19-1208
   Google Scholar
• Evatt BL, Robillard L. Establishing haemophilia care in the developing countries: using data to overcome the barrier of pessimism. Haemophilia. 2000;6(3):131–4. doi: 10.1046/j.1365-2516.2000.00417.x
   PubMed Web of Science ®Google Scholar
• Evatt BL, Black C, Batorova A, et al. Comprehensive care for haemophilia around the world. Haemophilia. 2004;10(Suppl 4):9–13. doi: 10.1111/j.1365-2516.2004.01010.x
   PubMedGoogle Scholar
• Peyvandi F, Duga S, Akhavan S, et al. Rare coagulation deficiencies. Haemophilia. 2002;8(3):308–321. doi: 10.1046/j.1365-2516.2002.00633.x
   PubMed Web of Science ®Google Scholar
• Chuansumrit A. Treatment of haemophilia in the developing countries. Haemophilia. 2003;9(4):387–390. doi: 10.1046/j.1365-2516.2003.00763.x
   PubMed Web of Science ®Google Scholar
• Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia. Haemophilia. 2020;26(Suppl 6):19–34. doi: 10.1111/hae.14046
   Google Scholar
• Rodeghiero F, Tosetto A, Abshire T, et al. ISTH_SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063–5. doi: 10.1111/j.1538-7836.2010.03975.x
   PubMed Web of Science ®Google Scholar
• Elbatarny M, Mollah S, Grabell J, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831–835. doi: 10.1111/hae.12503
   PubMed Web of Science ®Google Scholar
• Blanchette VS, Key NS, Ljung LR, et al. Definition in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935–9. doi: 10.1111/jth.12672
   PubMed Web of Science ®Google Scholar
• Borhany M, Fatima N, Abid M, et al. Application of the ISTH bleeding score in hemophilia. Transfus Apher Sci. 2018;57(4):556–560. doi: 10.1016/j.transci.2018.06.003
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Pongtanakul B, Kadegasem P, et al. Accurate bedside diagnostic kit for determining haemophilia a and B. Haemophilia. 2009;15(1):361–364. doi: 10.1111/j.1365-2516.2008.01783.x
   PubMed Web of Science ®Google Scholar
• Sasanakul W, Kadegasem P, Chaiyaratana W, et al. Simple and accurate bedside diagnostic kit for determining haemophilia a and B: a revised version. Haemophilia. 2013;19(1):e48–9. doi: 10.1111/hae.12047
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Youttananukorn W, Sirachainan N, et al. Direct transfer of data of people with haemophilia from the Thai Haemophilia treatment centre registry to the World Bleeding Disorders Registry of the World. Federation of Hemophilia. Haemophilia. 2022;28(2):e68–70. doi: 10.1111/hae.14496
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boy with severe hemophilia a. N Eng J Med. 2007;357(6):535–44. doi: 10.1056/NEJMoa067659
   PubMed Web of Science ®Google Scholar
• Miners AH, Sabin CA, Tolley KH, et al. Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia. PharmacoEconomics. 2002;20(11):759–774. doi: 10.2165/00019053-200220110-00005
   PubMed Web of Science ®Google Scholar
• Poonnoose P, Carneir JDA, Cruickshank AL, et al. Episodic replacement of clotting factor concentrates does not prevent bleeding or musculoskeletal damage-the MUSFIH study. Haemophilia. 2017;23(4):538–46. doi: 10.1111/hae.13242
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Krasaesub S, Angchaisuksiri P, et al. Survival analysis of patients with haemophilia at the international Haemophilia training Centre, Bangkok, Thailand. Haemophilia. 2004;10(5):542–549. doi: 10.1111/j.1365-2516.2004.00928.x
   PubMed Web of Science ®Google Scholar
• Chuansumrit A. The emerging national hemophilia coverage in Thailand: a result of routine service and research analysis. Siriraj Med J. 2006;58(12):1194–5.
   Google Scholar
• Sooksriwong C, Boonkerd L, Chanjaruporn F, et al. Incremental cost effectiveness analysis for haemophilia home-based care programme in Thailand. Haemophilia. 2012;18(4):e362–3. doi: 10.1111/j.1365-2516.2012.02871.x
   PubMed Web of Science ®Google Scholar
• Pattanaprateep O, Chuansumrit A, Kongsakon R. Cost-utility analysis of home-based care for treatment of Thai hemophilia a and B. Value Health Reg Issues. 2014;3:73–8. doi: 10.1016/j.vhri.2014.02.008
   PubMedGoogle Scholar
• Chuansumrit A, Isarangkura P, Hathirat P. Prophylactic treatment for hemophilia a patients: a pilot study. Southeast Asian J Trop Med Public Health. 1995;26(2):243–246.
   PubMedGoogle Scholar
• Wu R, Liang X, Yao W, et al. Significant reduction in hemarthrosisi in boys with severe hemophilia: the China hemophilic individualized low-dose secondary prophylaxis study. Res Pract Thromb Haemost. 2021;5(6):e12552. doi: 10.1002/rth2.12552
   PubMed Web of Science ®Google Scholar
• Pierce GF, Adediran M, Diop S, et al. Achieving access to haemophilia care in low-income and lower-middle-income countries; expanded humanitarian aid program of the world federation of hemophilia after 5 years. Lancet Haematol. 2022;9(9):e689–97. doi: 10.1016/S2352-3026(22)00209-5
   PubMed Web of Science ®Google Scholar
• Mannucci PM. Hemophilia therapy: the future has begun. Haematologica. 2020;105(3):545–553. doi: 10.3324/haematol.2019.232132
   PubMed Web of Science ®Google Scholar
• Teitel JM, Barnard D, Israels S, et al. Home management of haemophilia. Haemophilia. 2004;10(2):118–133. doi: 10.1046/j.1365-2516.2003.00853.x
   PubMed Web of Science ®Google Scholar
• Aschman DJ, Abshire TC, Shapiro AD, et al. A community-based partnership to promote information infrastructure for bleeding disorders. Am J Prev Med. 2011;41(6 Suppl 4):S332–7. doi: 10.1016/j.amepre.2011.09.018
   PubMed Web of Science ®Google Scholar
• Valentino LA, Baker JR, Butler R, et al. Integrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders. J Blood Med. 2021;12:897–911. doi: 10.2147/JBM.S325031
   PubMed Web of Science ®Google Scholar
• St-Louis J, Abad A, Funk S, et al. The hemophilia joint health score version 2.1 validation in adult patients study: a multicenter international study. Res Pract Thromb Haemost. 2022;6(2):e12690. doi: 10.1002/rth2.12690
   PubMed Web of Science ®Google Scholar
• Martinoli C, Della Casa Alberighi O, Di Minno G, et al. Development and definition of a simplified scanning procedure and scoring method for Haemophilia early arthropathy detection with ultrasound (HEAD-US). Thromb Haemost. 2013;109(6):1170–1179. doi: 10.1160/TH12-11-0874
   PubMed Web of Science ®Google Scholar
• Caviglia H, Landro ME, Daffunchio C, et al. Platelet rich plasma for chronic synovitis treatment in patients with haemophilia. Haemophilia. 2017;23(4):613–619. doi: 10.1111/hae.13212
   PubMed Web of Science ®Google Scholar
• Lillicrap D, Fijnvandraat K, Young G, et al. Patients with hemophilia a and inhibitors: prevention and evolving treatment paradigms. Expert Rev Hematol. 2020;13(4):313–321. doi: 10.1080/17474086.2020.1739518
   PubMed Web of Science ®Google Scholar
• Ljung RCR. How I manage patients with inherited haemophilia a and B and factor inhibitors. Br J Haematol. 2018;180(4):501–510. doi: 10.1111/bjh.15053
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Srichainan N, Natesirinilkul R, et al. Real-world evidence on health resources use among patients with haemophilia and inhibitors exhibiting severe bleeding episodes. Haemophilia. 2020;27(1):69–80. doi: 10.1111/hae.14194
   PubMed Web of Science ®Google Scholar
• Li Z, Chen Z, Liu G, et al. Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia a inhibitors. Res Pract Thromb Haemost. 2021;5(5):e12562. doi: 10.1002/rth2.12562
   PubMedGoogle Scholar
• Kitazawa T, Igawa T, Sampei Z, et al. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia a model. Nat Med. 2012;18(10):1570–1574. doi: 10.1038/nm.2942
   PubMed Web of Science ®Google Scholar
• Shima M, Hanabusa H, Taki M, et al. Factor VIII-mimetic function of humanized bispecific antibody in hemophilia a. N Engl J Med. 2016;374(21):2044–53. doi: 10.1056/NEJMoa1511769
   PubMed Web of Science ®Google Scholar
• Oldenburg J, Mahlangu JN, Kim B, et al. Emicizumab prophylaxis in hemophilia a with inhibitors. N Engl J Med. 2017;377(9):809–818. doi: 10.1056/NEJMoa1703068
   PubMed Web of Science ®Google Scholar
• Tang ASO, Leong TS, Ko CT, et al. Efficacy of reduced-dose emicizumab in haemophilia a with inhibitors: real world experience in east Malaysia [abstract]. Res Pract Thromb Haemost. 2021;5(Suppl 2):428. doi: 10.1097/01.HS9.0000977256.26946.4e
   Google Scholar
• Chuansumrit A, Sirachainan N, Jaovisidha S, et al. Effectiveness of monthly low dose emicizumab prophylaxis without 4-week loading doses among patients with haemophilia a with and without inhibitors: a case series report. Haemophilia. 2023;29(1):382–385. doi: 10.1111/hae.14707
   PubMedGoogle Scholar
• Bansal S, Donners AAMT, Fischer K, et al. Low dose emicizumab prophylaxis in haemophilia a patients: a pilot study from India. Haemophilia. 2023;29(3):931–934. doi: 10.1111/hae.14785
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood. 1987;69(2):454–459. doi: 10.1182/blood.V69.2.454.454
   PubMed Web of Science ®Google Scholar
• Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993;123(6):893–898. doi: 10.1016/S0022-3476(05)80384-1
   PubMed Web of Science ®Google Scholar
• Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84(2):160–74. doi: 10.1055/s-0037-1613992
   PubMed Web of Science ®Google Scholar
• Rojnuckarin P, Akkawat B, Intragumtornchai T. Von Willebrand factor (vWF) antigen levels and function in healthy thais. Southeast Asian J Trop Med Public Health. 2005;36(5):1292–1297.
   PubMedGoogle Scholar
• Oved JH, Lambert MP, Kowalska MA, et al. Population based frequency of naturally occurring loss-of-function variants in genes associated with platelet disorders. J Thromb Haemost. 2021;19(1):248–254. doi: 10.1111/jth.15113
   PubMed Web of Science ®Google Scholar
• Palma-Barqueros V, Revilla N, Sánchez A, et al. Inherited platelet disorders: an updated overview. Int J Mol Sci. 2021;22(9):4521. doi: 10.3390/ijms22094521
   PubMed Web of Science ®Google Scholar
• Donaldson JW, McKeever TM, Hall IP, et al. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study. Thorax. 2014;69(2):161–167. doi: 10.1136/thoraxjnl-2013-203720
   PubMed Web of Science ®Google Scholar
• Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009;17(7):860–871. doi: 10.1038/ejhg.2009.35
   PubMed Web of Science ®Google Scholar
• Tinkle B, Castori M, Berglund B, et al. Hypermobile ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and ehlers-Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017;175(1):48–69. doi: 10.1002/ajmg.c.31538
   PubMed Web of Science ®Google Scholar
• Federici AB, Bucciarelli P, Castaman G, et al. The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease. Blood. 2014;123(26):4037–4044. doi: 10.1182/blood-2014-02-557264
   PubMed Web of Science ®Google Scholar
• Relke N, Kuthiala S, Grabell J, et al. The bleeding score: useful in predicting spontaneous bleeding events in adults with bleeding of unknown cause? Haemophilia. 2020;26(2):e31–e33. doi: 10.1111/hae.13775
   PubMed Web of Science ®Google Scholar
• James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280–300. doi: 10.1182/bloodadvances.2020003265
   PubMed Web of Science ®Google Scholar
• Connell NT, Flood VH, Brignardello-Petersen R, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021;5(1):301–25. doi: 10.1182/bloodadvances.2020003264
   PubMed Web of Science ®Google Scholar
• Leebeek FW, Eikenboom JC. Von Willebrand’s disease. N Engl J Med. 2016;375(21):2067–80. doi: 10.1056/NEJMra1601561
   PubMed Web of Science ®Google Scholar
• Pecci A, Ma X, Savoia A, et al. MYH9: structure, functions and role of non-muscle myosin IIA in human disease. Gene. 2018;664:152–167. doi: 10.1016/j.gene.2018.04.048
   PubMed Web of Science ®Google Scholar
• Gresele P, Harrison P, Gachet C. Subcommittee on platelet physiology of the international society on thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost. 2015;13(2):314–322. doi: 10.1111/jth.12792
   PubMed Web of Science ®Google Scholar
• Thomas W, Downes K, Desborough MJR. Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management. Haemophilia. 2020;26(6):946–957. doi: 10.1111/hae.14174
   PubMed Web of Science ®Google Scholar
• Natesirinilkul R, Sosothikul D, Komwilaisak P, et al. MYH9 disorder: identification and a novel mutation in patients with macrothrombocytopenia. Pediatr Blood Cancer. 2021;68(7):e29055. doi: 10.1002/pbc.29055
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Martinowitz U, Wangruangsathit S, et al. Stability of fibrin glue in body fluid. Rama Med J. 2000;23:1–7.
   Google Scholar
• Khongjaroensakun N, Paisooksantivatana K, Santiwatana S, et al. A simple and applicable method for human platelet lysate preparation using citrate blood. Blood Lab Med. 2022;53(5):e109–12. doi: 10.1093/labmed/lmab116
   PubMed Web of Science ®Google Scholar
• Suwannuraks M, Chuansumrit A, Sriudomporn N. The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patients. Haemophilia. 1999;5(2):106–108. doi: 10.1046/j.1365-2516.1999.t01-1-00283.x
   PubMed Web of Science ®Google Scholar
• Poon MC, D’Oiron R, Von Depka M, et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann’s thrombasthenia: results of an international survey. J Thromb Haemost. 2004;2(7):1096–1103. doi: 10.1111/j.1538-7836.2004.00767.x
   PubMed Web of Science ®Google Scholar
• Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014;167(3):304–326. doi: 10.1111/bjh.13058
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Garagiola I, Biguzzi E. Advances in the treatment of bleeding disorders. J Thromb Haemost. 2016;14(11):2095–2106. doi: 10.1111/jth.13491
   PubMed Web of Science ®Google Scholar
• Menegatti M, Palla R. Clinical and laboratory diagnosis of rare coagulation disorders (RCDs). Thromb Res. 2020 Dec;196:603–608. doi: 10.1016/j.thromres.2019.09.006
   PubMed Web of Science ®Google Scholar
• Palla R, Siboni SM, Menegatti M, et al. Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders. Thromb Res. 2016;148:128–134. doi: 10.1016/j.thromres.2016.11.008
   PubMed Web of Science ®Google Scholar
• Gresele P, Falcinelli E, Bury L, et al. The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: communication from the ISTH SSC subcommittee on platelet physiology. J Thromb Haemost. 2021;19(5):1364–1371. doi: 10.1111/jth.15263
   PubMed Web of Science ®Google Scholar
• Rauch A, Valentino LA, Mills K, et al. Big picture initiatives in bleeding disorders. Haemophilia. 2022;28(Suppl 4):53–60. doi: 10.1111/hae.14532
   PubMedGoogle Scholar
• Di Minno MN, Dolce A, Mariani G, et al. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thromb Haemost. 2013;109(6):1051–9. doi: 10.1160/TH12-10-0740
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Parapakpenjune S, Natesirinilkul R, et al. Phenotypic and genotypic analysis of patients with congenital factor VIII deficiency in a multicenter study in Thailand. Ped Hematol Oncol J. 2022;7(4):130–5. doi: 10.1016/j.phoj.2022.08.003
   Google Scholar
• Takamiya O. Genetic polymorphism (Arg353–>Gln) in coagulation factor VII gene and factor VII levels (coagulant activity, antigen and binding ability to tissue factor) in 101 healthy Japanese. Scand J Clin Lab Invest. 1995;55(3):211–5. doi: 10.3109/00365519509089615
   PubMed Web of Science ®Google Scholar
• Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734–739. doi: 10.1111/j.1471-0528.1990.tb16249.x
   PubMedGoogle Scholar
• McGrath M, Quint EH, Weyand AC. Depression in adolescents and young adults with heavy menstrual bleeding in a referral clinic setting. Am J Hematol. 2021;96(4):E105–8. doi: 10.1002/ajh.26093
   PubMed Web of Science ®Google Scholar
• Weyand AC, Fitzgerald KD, McGrath M, et al. Depression in adolescent females with heavy menstrual bleeding. J Pediatr. 2022;240:171–6. doi: 10.1016/j.jpeds.2021.09.007
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Sasanakul W, Sirachainan N, et al. Three-decade successive establishment of care for women/girls from families with haemophilia. Appl Clin Genet. 2022;15:133–143. doi: 10.2147/TACG.S381683
   PubMed Web of Science ®Google Scholar
• Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AH, et al. Bleeding in carriers of hemophilia. Blood. 2006;108(1):52–6. doi: 10.1182/blood-2005-09-3879
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Sasanakul W, Promsonthi P, et al. Prenatal diagnosis for haemophilia: the Thai experience. Haemophilia. 2016;22(6):880–885. doi: 10.1111/hae.13002
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Isarangkura P, Chantanakajornfung A, et al. The efficacy and safety of lyophilized cryoprecipitate in hemophilia a. J Med Assoc Thai. 1999;82 Suppl 1(Suppl 1):S69–73.
   PubMedGoogle Scholar
• El-Ekiaby M, Goubran HA, Radosevich M, et al. Pharmacokinetic study of minipooled solvent/detergent-filtered cryoprecipitate factor VIII. Haemophilia. 2011;17(5):e884–8. doi: 10.1111/j.1365-2516.2011.02511.x
   PubMed Web of Science ®Google Scholar
• Sasanakul W, Chuansumrit A, Rurgkhum S, et al. DNA extraction and amplification of 10-day, room temperature blood samples. J Med Assoc Thai. 1999;82(Suppl 1):S186–9.
   PubMedGoogle Scholar
• Kadegasem P, Rurgkhum S, Sasanakul W, et al. DNA extraction from buffy coat sent by mail without ice. Thai J Hematol Transf Med. 2001;11:167–71.
   Google Scholar
• Goodeve AC, Chuansumrit A, Sasanakul W, et al. A comparison of the allelic frequencies of ten DNA polymorphisms associated with factor VIII and factor IX genes in Thai and Western European populations. Blood Coagul Fibrinolysis. 1994;5(1):29–35. doi: 10.1097/00001721-199402000-00005
   PubMed Web of Science ®Google Scholar
• Goodeve AC, Tagariello G, Chuansumrit A, et al. A rapid and cost effective method for analysis of dinucleotide repeat polymorphisms in the factor VIII gene. Blood Coagul Fibrinolysis. 1996;7(7):672–677. doi: 10.1097/00001721-199610000-00002
   PubMed Web of Science ®Google Scholar
• Rossetti LC, Radic CP, Larripa IB, et al. Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int22h and int1h hotspots in the factor VIII gene. J Thromb Haemost. 2008;6(5):830–836. doi: 10.1111/j.1538-7836.2008.02926.x
   PubMed Web of Science ®Google Scholar
• Megy K, Downes K, Morel-Kopp MC, et al. GoldVariants, a resource for sharing genetic variants detected in bleeding, thrombotic, and platelet disorders: communication from the ISTH SCC subcommittee on genomics in thrombosis and hemostasis. J Thromb Haemost. 2021;19(10):2612–7. doi: 10.1111/jth.15459
   PubMed Web of Science ®Google Scholar
• Pezeshkpoor B, Oldenburg J, Pavlova A. Insights into the molecular genetic of hemophilia a and hemophilia B: the relevance of genetic testing in routine clinical practice. Hamostaseologie. 2022;42(6):390–399. doi: 10.1055/a-1945-9429
   PubMedGoogle Scholar